At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 115 enrolled
Drug / intervention
Ropivacaine 0.5% +2 moredrug
Likely dose
Naprosyn 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison Between Femoral Nerve Block and Adductor Canal Block for Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Ropivacaine 0.5%, Percocet 7.5/325, and 1 other intervention for Anterior Cruciate Ligament Reconstruction. Completed, enrolled 115 participants across 1 site.
Detailed Summary
The objective of this study is to compare the pain control benefit of two different types of nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedNov 2015
Primary CompletionApr 2016
TodayJul 2026
First PostedNov 13, 2015
Enrollment StartNov 1, 2015
Primary CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.6 years ago
Interventions
Ropivacaine 0.5%drug
Ropivacaine 0.5% will be administered to the femoral nerve or adductor canal.
Percocet 7.5/325drug
Percocet 7.5/325 will taken as needed up to every four hours.
Naprosyn 500 mgdrug
Naprosyn 500 mg will be taken twice daily.